Ketomaf

Ketomaf

Composition:

Each film coated tablet of Ketomaf contains:

Ketoprofen …………………………………… 100 mg.

DESCRIPTION:

Ketomaf is an aryl carboxylic acid derivative. It is one of (NSAIDs) group with anti-inflammatory, analgesic and antipyretic effects. It inhibits PG synthesis. Ketomaf enters the synovial fluid and remains there at higher levels than in plasma after – 4 hrs. from oral administration. Ketomaf also can cross the placental barrier.

INDICATION:

Long term treatment of the following:

– Chronic inflammatory rheumatic disease e.g.: rheumatoid arthritis.

– Ankylosing spondylitis or related syndromes.

– Reiter’s syndrome and psoriatic arthritis, certain. painful, incapacitating forms of arthrosis.

– Dental and gum pain.

Short term symptomatic treatment of acute exacerbations of the following:

– Non-articular rheumatism (acute painful shoulder, tendonitis, ….).

– Arthrosis.

– Microcrystalline arthritis.

– Radiculalgia.

– Severe low back pain.

DOSAGE:

Initial dose:

3 tablets / day in 3 divided doses.

Maintenance dose:

1-2 tablets / day in one or two divided doses.

Storage Conditions:

– Keep the medicine in a dry place at a temperature below 30 °C.

– Keep the medicine out of the reach of children.

– Protect the medicine from direct sunlight.

– Do not use Ketomaf tablets after expire date.